<--- Back to Details
First PageDocument Content
Epidemiology / Pharmacoepidemiology / Pharmacology / Boehringer Ingelheim / McGill University
Date: 2011-07-11 09:16:00
Epidemiology
Pharmacoepidemiology
Pharmacology
Boehringer Ingelheim
McGill University

Microsoft Word - Program_2011_v3.docx

Add to Reading List

Source URL: www.imbei.uni-mainz.de

Download Document from Source Website

File Size: 50,45 KB

Share Document on Facebook

Similar Documents

PORTAL Program on Regulation, Therapeutics, And Law Division of Pharmacoepidemiology and Pharmacoeconomics Harvard Medical School and Brigham & Women’s Hospital

DocID: 1unul - View Document

Opioids, Aspirin, NSAIDs, sCOX-2 Inhibitors & Breast Cancer Recurrence: Pharmacoepidemiology studies using DBCG data Deirdre Cronin Fenton Associate Professor, Ph.D.

DocID: 1s8CN - View Document

Amphetamine / Methylphenidate / Attention deficit hyperactivity disorder / Euphoriants / Stimulants / Attention deficit hyperactivity disorder management / Lisdexamfetamine / Dextroamphetamine / Prescription drug / Adult attention deficit hyperactivity disorder / Pemoline / Medical prescription

prilTreatments for Attention Deficit Hyperactivity Disorder in Adults FINAL PHARMACOEPIDEMIOLOGY REPORT

DocID: 1pBj0 - View Document

Epidemiology / Pharmacoepidemiology / Pharmacology / Boehringer Ingelheim / McGill University

Microsoft Word - Program_2011_v3.docx

DocID: 1oyUA - View Document

pharmacoepidemiology and drug safety (in press) Published online in Wiley InterScience (www.interscience.wiley.com). DOI: pds.980 ORIGINAL REPORT An analysis of the significant variation in psychostimulant use ac

DocID: 1kCxI - View Document